Status:
UNKNOWN
Comparison of Safety and Efficacy of Two Different Drug Eluting Stents Implanted Into Saphenous Vein Grafts
Lead Sponsor:
National Institute of Cardiology, Warsaw, Poland
Conditions:
Stenosis in Saphenous Vein Graft, Drug Eluting Stent
Eligibility:
All Genders
18-80 years
Phase:
PHASE3
Brief Summary
Drug eluting stents significantly reduced the rate of in-stent restenosis in coronary arteries. There are several kinds of DES i.e. eluting the drug either from stable or biodegradable polymer. The ty...
Eligibility Criteria
Inclusion
- Atherosclerotic lesion in saphenous vein grafts causing angiographic stenosis ≥70%
- Stable coronary artery disease or non ST segment elevation acute coronary syndrome
- Reference segment diameter in range of 2.5-4.5mm
Exclusion
- Cardiogenic shock
- Contraindications to prolonged dual antiplatelet therapy
- Female of child birth potential unless on effective contraception
- Other medical condition that may limit survival
Key Trial Info
Start Date :
February 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2011
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00766129
Start Date
February 1 2008
End Date
December 1 2011
Last Update
July 6 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute of Cardiology
Warsaw, Poland, 04-628